A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
K36 Therapeutics, Inc.
Varian, a Siemens Healthineers Company
Blue Earth Therapeutics Ltd
DL Analytics
NanOlogy, LLC
AgonOx, Inc.
Eli Lilly and Company
Pathos AI, Inc.
RefleXion Medical
Marengo Therapeutics, Inc.
Lipac Oncology LLC
Eli Lilly and Company
Advanced Accelerator Applications
Endocyte